395 related articles for article (PubMed ID: 18400885)
21. Similar effect of CRF
Spinieli RL; Leite-Panissi CRA
Brain Res Bull; 2018 Mar; 137():187-196. PubMed ID: 29246866
[TBL] [Abstract][Full Text] [Related]
22. Anxiogenic and antinociceptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice.
Miguel TT; Nunes-de-Souza RL
Horm Behav; 2011 Aug; 60(3):292-300. PubMed ID: 21723867
[TBL] [Abstract][Full Text] [Related]
23. Corticotropin-releasing factor modulates maternal separation-induced ultrasonic vocalization in rat pups via activation of CRF1 receptor.
Ise S; Nagano N; Okuda S; Ohta H
Brain Res; 2008 Oct; 1234():59-65. PubMed ID: 18703034
[TBL] [Abstract][Full Text] [Related]
24. Role of corticotropin releasing factor (CRF) receptors 1 and 2 in CRF-potentiated acoustic startle in mice.
Risbrough VB; Hauger RL; Pelleymounter MA; Geyer MA
Psychopharmacology (Berl); 2003 Nov; 170(2):178-87. PubMed ID: 12845406
[TBL] [Abstract][Full Text] [Related]
25. Importance of CRF receptor-mediated mechanisms of the bed nucleus of the stria terminalis in the processing of anxiety and pain.
Tran L; Schulkin J; Greenwood-Van Meerveld B
Neuropsychopharmacology; 2014 Oct; 39(11):2633-45. PubMed ID: 24853772
[TBL] [Abstract][Full Text] [Related]
26. Corticotropin-releasing hormone modulates airway vagal preganglionic neurons of Sprague-Dawley rats at multiple synaptic sites via activation of its type 1 receptors: Implications for stress-associated airway vagal excitation.
Guo Y; Yan X; Chen X; He D; Zeng M; Chen Y; Xia C; Qiu D; Wang J
Neuroscience; 2017 Jul; 355():101-112. PubMed ID: 28499969
[TBL] [Abstract][Full Text] [Related]
27. The CRF1 receptor mediates the excitatory actions of corticotropin releasing factor (CRF) in the developing rat brain: in vivo evidence using a novel, selective, non-peptide CRF receptor antagonist.
Baram TZ; Chalmers DT; Chen C; Koutsoukos Y; De Souza EB
Brain Res; 1997 Oct; 770(1-2):89-95. PubMed ID: 9372207
[TBL] [Abstract][Full Text] [Related]
28. Dopamine and corticotropin-releasing factor synergistically alter basolateral amygdala-to-medial prefrontal cortex synaptic transmission: functional switch after chronic cocaine administration.
Orozco-Cabal L; Liu J; Pollandt S; Schmidt K; Shinnick-Gallagher P; Gallagher JP
J Neurosci; 2008 Jan; 28(2):529-42. PubMed ID: 18184795
[TBL] [Abstract][Full Text] [Related]
29. Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats.
Han JS; Adwanikar H; Li Z; Ji G; Neugebauer V
Mol Pain; 2010 Feb; 6():10. PubMed ID: 20144185
[TBL] [Abstract][Full Text] [Related]
30. Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.
McCarthy JR; Heinrichs SC; Grigoriadis DE
Curr Pharm Des; 1999 May; 5(5):289-315. PubMed ID: 10213797
[TBL] [Abstract][Full Text] [Related]
31. Stimulation of lateral septum CRF2 receptors promotes anorexia and stress-like behaviors: functional homology to CRF1 receptors in basolateral amygdala.
Bakshi VP; Newman SM; Smith-Roe S; Jochman KA; Kalin NH
J Neurosci; 2007 Sep; 27(39):10568-77. PubMed ID: 17898228
[TBL] [Abstract][Full Text] [Related]
32. Kappa opioid receptor activation in the amygdala disinhibits CRF neurons to generate pain-like behaviors.
Hein M; Ji G; Tidwell D; D'Souza P; Kiritoshi T; Yakhnitsa V; Navratilova E; Porreca F; Neugebauer V
Neuropharmacology; 2021 Mar; 185():108456. PubMed ID: 33444637
[TBL] [Abstract][Full Text] [Related]
33. Differential contributions of vasopressin V1A and oxytocin receptors in the amygdala to pain-related behaviors in rats.
Cragg B; Ji G; Neugebauer V
Mol Pain; 2016; 12():. PubMed ID: 27837170
[TBL] [Abstract][Full Text] [Related]
34. Synaptic plasticity in the amygdala in a model of arthritic pain: differential roles of metabotropic glutamate receptors 1 and 5.
Neugebauer V; Li W; Bird GC; Bhave G; Gereau RW
J Neurosci; 2003 Jan; 23(1):52-63. PubMed ID: 12514201
[TBL] [Abstract][Full Text] [Related]
35. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.
Grigoriadis DE; Liu XJ; Vaughn J; Palmer SF; True CD; Vale WW; Ling N; De Souza EB
Mol Pharmacol; 1996 Sep; 50(3):679-86. PubMed ID: 8794910
[TBL] [Abstract][Full Text] [Related]
36. Pain-related increase of excitatory transmission and decrease of inhibitory transmission in the central nucleus of the amygdala are mediated by mGluR1.
Ren W; Neugebauer V
Mol Pain; 2010 Dec; 6():93. PubMed ID: 21162731
[TBL] [Abstract][Full Text] [Related]
37. Lack of interaction between etifoxine and CRF1 and CRF2 receptors in rodents.
Verleye M; André N; Gillardin JM
Neurosci Res; 2006 Sep; 56(1):53-60. PubMed ID: 16769145
[TBL] [Abstract][Full Text] [Related]
38. CRF1 and CRF2 receptors in the bed nucleus of the stria terminalis modulate the cardiovascular responses to acute restraint stress in rats.
Oliveira LA; Almeida J; Benini R; Crestani CC
Pharmacol Res; 2015; 95-96():53-62. PubMed ID: 25829333
[TBL] [Abstract][Full Text] [Related]
39. Opposing roles of corticotropin-releasing factor and neuropeptide Y within the dorsolateral bed nucleus of the stria terminalis in the negative affective component of pain in rats.
Ide S; Hara T; Ohno A; Tamano R; Koseki K; Naka T; Maruyama C; Kaneda K; Yoshioka M; Minami M
J Neurosci; 2013 Apr; 33(14):5881-94. PubMed ID: 23554470
[TBL] [Abstract][Full Text] [Related]
40. Corticotrophin-releasing factor 1 activation in the central amygdale and visceral hyperalgesia.
Taché Y
Neurogastroenterol Motil; 2015 Jan; 27(1):1-6. PubMed ID: 25557223
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
